Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Deep whole genome sequence data for the CEPH 1463 family

PROVIDER: PRJEB3246 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR174310_1.fastq.gz	Fastqsanger.gz
	ERR174310_2.fastq.gz	Fastqsanger.gz
	ERR174311_1.fastq.gz	Fastqsanger.gz
	ERR174311_2.fastq.gz	Fastqsanger.gz
	ERR174312_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 64

Similar Datasets

Project description:Long range mate-pair genome sequence data for the CEPH 1463 family

| PRJEB1813 | ENA

Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants

Project description:We have combined high-quality genome sequencing and RNA-sequencing data within a 17-individual, three generation family. Using these data, we have contrasted cis-acting expression, allele-specific expression and splicing quantitative trait loci (collectively termed eQTLs) within the family to eQTLs discovered within a cell-type and ethnicity-matched population sample. We identified that eQTL that exhibit larger effects in the family compared to the population are enriched for rare regulatory and splicing variants and were more likely to influence essential genes. In addition, we identify several large effect-size eQTLs within the family for genes involved in complex disease. Through analysis of eQTLs in a large family we also report the utility of non-coding genome annotation to predicting the effect of rare non-coding variants. We find that a combination of distance to the transcription start site, evolutionary constraint and epigenetic annotation is considerably more informative for predicting the consequence of rare non-coding variants than for common variants. In summary, through transcriptome analyses within a large family we are able to identify the contribution of rare non-coding variants to expression phenotypes and further demonstrate the predictive potential of diverse non-coding genome annotation for interpretation of the impact of rare non-coding variants. RNA-Sequencing of CEPH/UTAH family 1463

2014-09-01 | E-GEOD-56961 | biostudies-arrayexpress

Genetic variation in radiation-induced cell death

Project description:We used microarrays to measure the expression levels of genes in irradiated immortalized B cells, lymphoblastoid cells, from members of Centre d'Etude du Polymorphisme Humain (CEPH) Utah pedigrees. Data were collected for cells at baseline and 2 hours and 6 hours after exposure to 10 Gy of ionizing radiation (IR). We measured the expression levels of genes in irradiated immortalized B cells, lymphoblastoid cells, from members of 30 Centre d'Etude du Polymorphisme Humain (CEPH) Utah pedigrees (CEPH 1331, 1332, 1333, 1341, 1344, 1346, 1347, 1349, 1354, 1356, 1357, 1358, 1362, 1408, 1413, 1416, 1418, 1420, 1421, 1423, 1424, 1444, 1447, 1451, 1454, 1456, 1458, 1463, 1477, 1582). Cells were irradiated at 10 Gy in a 137Cs irradiator. Cells were harvested prior to radiation and at 2 and 6 hours following exposure to IR.

2011-08-03 | E-GEOD-26835 | biostudies-arrayexpress

Homo sapiens strain:CEPH/UTAH PEDIGREE 1463

Project description:Homo sapiens CEPH/UTAH PEDIGREE 1463 Genome sequencing project

| PRJNA62295 | ENA

Homo sapiens strain:CEPH/UTAH Pedigree 1463

Project description:Homo sapiens CEPH/UTAH Pedigree 1463 genome sequencing project

| PRJNA52009 | ENA

human

Project description:CEPH/UTAH PEDIGREE 1463 BACslibrary VMRC53 Genome sequencing and assembly

| PRJNA647458 | ENA

Homo sapiens

Project description:Homo sapiens CEPH/UTAH Pedigree 1463 amplicon sequencing project

| PRJNA89153 | ENA

Homo sapiens

Project description:Homo sapiens whole genome sequencing of Ceph/Utah Pedigree 1463- NA12878, NA12891, and NA12892 Genome sequencing

| PRJNA323611 | ENA

Deep whole genome sequence data for the Y117 family

Project description:Deep whole genome sequence data for the Y117 family using 2x250 reads

| PRJEB4252 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data